Aesthetic Product Distributor Due Diligence: A B2B Checklist
A practical checklist for evaluating an aesthetic product distribution project through territory, portfolio fit, responsible entities, documentation, packaging and channel readiness.
Aesthetic product distributor due diligence should begin before exclusivity, pricing or document-release discussions. The purpose is not to collect the largest possible file package. It is to determine whether the proposed territory, product scope, responsible entities and commercial route are sufficiently clear for a qualified project review.
The checklist below gives distributors, brand owners and supplier teams a common sequence. It helps separate public portfolio information from project-level confirmation and controlled records.
1. Define the territory and commercial role
Record the country or territory, buyer role, expected route to market and organisations that may participate. A distributor, importer, brand owner and commercial coordinator can have different responsibilities. Those roles should not be inferred from a website image or a general company description.
Questions to resolve include:
- Which territory is under review?
- Who will purchase, import, distribute or own the brand?
- Which organisation will review local regulatory and labelling requirements?
- Is the discussion exploratory, project-qualified or ready for a commercial proposal?
The distribution project page provides the appropriate route for submitting this context.
2. Check portfolio fit before requesting terms
Identify the categories and presentations that match the buyer’s channel. Compare the public product portfolio as a starting point, then record the specific format, pack direction and target-market question that requires confirmation.
A representative syringe, vial, carton or kit does not confirm final artwork, formula, registration status or availability in every market. If several formats are under review, list them separately. This prevents information for one configuration from being applied to another.
3. Identify the responsible entities accurately
Innovision Bio coordinates B2B commercial and project discussions. GuangLong is the manufacturing and R&D entity for relevant product lines where stated. A distribution review should preserve that distinction and separately identify any destination-market roles.
Before a buyer uses a company name in artwork, product communication or a regulatory file, the intended role and supporting scope should be checked for the selected project. A broad group description is not evidence that every entity holds every certificate, report or market responsibility.
4. Map each document to a decision
Ask for information that supports the next decision, not an undifferentiated archive. For every requested record, state the product or batch, document holder, version, intended reviewer and question it should answer.
Public information can support an initial comparison. Project-level parameters can follow once the scope is qualified. Batch, formula, process and controlled-document records should use the authorised release path. The packaging and documentation guide explains this layered approach.
5. Review packaging and localisation as project inputs
Confirm the primary presentation, unit count, accessories, protective packaging, secondary carton, required languages and artwork responsibilities. Packaging decisions affect the questions that follow, but a concept image is not final artwork or a verified component specification.
Localisation is more than translation. Product naming, permitted statements, mandatory information and responsible-party details may require target-market review. Record which party owns each decision and which items remain open.
6. Test channel and operating readiness
A useful distributor discussion includes the current channel, customer profile, relevant team capability, launch sequence and forecast assumptions. Forecasts should be treated as planning inputs rather than guaranteed demand.
Commercial questions may include minimum viable launch scope, territory priorities, sample or evaluation needs, communication responsibilities and the conditions for reviewing exclusivity. These points should follow portfolio and role alignment, not precede it.
7. Close with an auditable next step
Create a short review record containing:
- territory, buyer role and proposed commercial route;
- selected categories, formats and packaging direction;
- entities and responsibilities still to be confirmed;
- documents required for the next decision and their intended use;
- open technical, regulatory and commercial questions;
- owner and target date for the next action.
The OEM/ODM project brief can be used when customisation is part of the discussion. When the scope is ready, submit the record through the qualified B2B contact route.
A practical qualification outcome
Good due diligence does not guarantee a partnership. It produces a clearer decision: proceed to a defined project review, request a limited set of relevant information, revise the proposed scope or stop before both sides incur avoidable cost.
This article is for professional B2B planning only. It is not medical, legal or regulatory advice, a product registration, a market authorisation, a promise of exclusivity or a public offer. Product scope, documentation, roles and target-market requirements must be confirmed for each project.